Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,317 public trials 177 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.

NCT00380224

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Little Rock, Arkansas, United States

Little Rock, Arkansas, United States

Anaheim, California, United States

Anaheim, California, United States

View all 67 locations

View Trial Details

Completed

Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?

NCT00269464

Conditions: Anxiety Disorders, Mental Disorders, Obsessive Compulsive Disorder, +3 more
Locations: Not specified

View Trial Details

Completed

Open Label Extension Study of Bifeprunox

NCT00366171

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Little Rock, Arkansas, United States

Little Rock, Arkansas, United States

Anaheim, California, United States

Anaheim, California, United States

View all 83 locations

View Trial Details

Completed

Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia

NCT00208143

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Cocaine-Related Disorders, +8 more
Locations: Creighton University Psychiatry and Research Center Omaha, Nebraska, United States

View Trial Details

Completed

Galantamine for Cognitive Deficits in Schizophrenia

NCT00463879

Conditions: Behavior, Cognition Disorders, Mental Disorders, +4 more
Locations: Connecticut Mental Health Center, Yale School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

Effects of Atomoxetine on Cognitive Function in Schizophrenia

NCT00420498

Conditions: Behavior, Cigarette Smoking, Cognition, +6 more
Locations: Connecticut Mental Health Center, SAC-115 New Haven, Connecticut, United States

View Trial Details

Completed

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

NCT00265551

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Little Rock, Arkansas, United States

Cerritos, California, United States

Costa Mesa, California, United States

La Mesa, California, United States

View all 35 locations

View Trial Details

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

NCT00458107

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Glendale, California, United States

View Trial Details

Completed

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

NCT00541996

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

NCT00505973

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Ikebukuro, Toshima-ku, Japan

View Trial Details

Schizophrenia

Schizophrenia trial results

Related conditions